title: Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma.
abstract: Nine of 11 patients with hepatoblastoma treated with cisplatin (DDP) based chemotherapy had a complete (CR) or partial (PR) remission. Five of these patients had measurable pulmonary disease and four achieved a CR of pulmonary lesions. The average interval of disease control following DDP was three times that of Adriamycin (ADR). DDP is an effective agent in the treatment of hepatoblastoma.
authors.forename: E C
authors.initials: EC
authors.lastname: Douglass
authors.forename: A A
authors.initials: AA
authors.lastname: Green
authors.forename: E
authors.initials: E
authors.lastname: Wrenn
authors.forename: J
authors.initials: J
authors.lastname: Champion
authors.forename: M
authors.initials: M
authors.lastname: Shipp
authors.forename: C B
authors.initials: CB
authors.lastname: Pratt
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D002675:Child, Preschool; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007223:Infant; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D011379:Prognosis; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D002945:Cisplatin; D005472:Fluorouracil